JP2015529198A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529198A5
JP2015529198A5 JP2015528571A JP2015528571A JP2015529198A5 JP 2015529198 A5 JP2015529198 A5 JP 2015529198A5 JP 2015528571 A JP2015528571 A JP 2015528571A JP 2015528571 A JP2015528571 A JP 2015528571A JP 2015529198 A5 JP2015529198 A5 JP 2015529198A5
Authority
JP
Japan
Prior art keywords
compound
immunogenic carrier
conjugate
protein
nhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015528571A
Other languages
English (en)
Japanese (ja)
Other versions
JP6131415B2 (ja
JP2015529198A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/055724 external-priority patent/WO2014031600A1/en
Publication of JP2015529198A publication Critical patent/JP2015529198A/ja
Publication of JP2015529198A5 publication Critical patent/JP2015529198A5/ja
Application granted granted Critical
Publication of JP6131415B2 publication Critical patent/JP6131415B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015528571A 2012-08-21 2013-08-20 イムノアッセイに使用するためのクエチアピンのハプテン Active JP6131415B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261691462P 2012-08-21 2012-08-21
US61/691,462 2012-08-21
PCT/US2013/055724 WO2014031600A1 (en) 2012-08-21 2013-08-20 Haptens of quetiapine for use in immunoassays

Publications (3)

Publication Number Publication Date
JP2015529198A JP2015529198A (ja) 2015-10-05
JP2015529198A5 true JP2015529198A5 (cg-RX-API-DMAC7.html) 2016-04-14
JP6131415B2 JP6131415B2 (ja) 2017-05-24

Family

ID=49081009

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015528571A Active JP6131415B2 (ja) 2012-08-21 2013-08-20 イムノアッセイに使用するためのクエチアピンのハプテン

Country Status (10)

Country Link
US (1) US9304126B2 (cg-RX-API-DMAC7.html)
EP (2) EP3305784B1 (cg-RX-API-DMAC7.html)
JP (1) JP6131415B2 (cg-RX-API-DMAC7.html)
CN (2) CN104736536B (cg-RX-API-DMAC7.html)
AU (2) AU2013305935B2 (cg-RX-API-DMAC7.html)
CA (1) CA2882557C (cg-RX-API-DMAC7.html)
ES (2) ES2822907T3 (cg-RX-API-DMAC7.html)
PL (2) PL3305784T3 (cg-RX-API-DMAC7.html)
PT (2) PT3305784T (cg-RX-API-DMAC7.html)
WO (1) WO2014031600A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス,インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
ES2822004T3 (es) 2012-08-21 2021-04-28 Janssen Pharmaceutica Nv Anticuerpos contra quetiapina y uso de los mismos
WO2014031584A1 (en) 2012-08-21 2014-02-27 Janssen Pharmaceutica Nv Haptens of aripiprazole and their use in immunoassays
JP6389176B2 (ja) 2012-08-21 2018-09-12 ヤンセン ファーマシューティカ エヌ.ベー. アリピプラゾールハプテンに対する抗体及びその使用
PT3305784T (pt) * 2012-08-21 2020-10-23 Janssen Pharmaceutica Nv Haptenos de quetiapina para utilização em ensaios imunológicos
CN108517014A (zh) 2012-08-21 2018-09-11 詹森药业有限公司 利培酮半抗原的抗体及其用途
JP6450314B2 (ja) 2012-08-21 2019-01-09 ヤンセン ファーマシューティカ エヌ.ベー. クエチアピンハプテンに対する抗体及びその使用
JP6389177B2 (ja) 2012-08-21 2018-09-12 ヤンセン ファーマシューティカ エヌ.ベー. オランザピンハプテンに対する抗体及びその使用
CN107043424B (zh) 2012-08-21 2021-03-16 詹森药业有限公司 利培酮的抗体及其用途
AU2013305901B2 (en) 2012-08-21 2017-10-26 Saladax Biomedical Inc. Antibodies to olanzapine and use thereof
CN104736561B (zh) 2012-08-21 2018-06-12 詹森药业有限公司 帕潘立酮的抗体及其用途
AU2013305879B2 (en) 2012-08-21 2017-10-12 Saladax Biomedical Inc. Antibodies to aripiprazole and use thereof
BR112017017719A2 (pt) * 2015-02-20 2018-04-10 Idexx Lab Inc imunoensaio homogêneo com compensação para sinal antecedente
CA3008809A1 (en) 2015-12-17 2017-06-22 Janssen Pharmaceutica Nv Antibodies to risperidone and use thereof
WO2017106508A1 (en) 2015-12-17 2017-06-22 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
US11422136B2 (en) 2017-10-19 2022-08-23 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
CN113811356B (zh) 2019-03-08 2025-01-03 美国迈胜医疗系统有限公司 用于粒子治疗系统的准直器和射程调节器
CN111808046B (zh) * 2020-06-30 2022-11-11 杭州同舟生物技术有限公司 一种喹硫平人工半抗原、人工抗原及其制备方法和应用
CN116354904B (zh) * 2023-04-26 2023-08-01 北京丹大生物技术有限公司 一种喹硫平衍生物半抗原、抗原、抗喹硫平抗体及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
NO305125B1 (no) 1992-05-29 1999-04-06 Lilly Industries Ltd Farmas°ytiske forbindelser
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
US5395933A (en) 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
ES2297142T3 (es) 2002-03-28 2008-05-01 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina y su uso como antagonistas del receptor de dopamina para el tratamiento de trastornos psicoticos.
AU2003264915A1 (en) 2002-08-05 2004-02-25 Eli Lilly And Company Piperazine substituted aryl benzodiazepines
PT1664007E (pt) * 2003-09-23 2010-02-15 Fermion Oy Preparação de quetiapina
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
FR2878850B1 (fr) * 2004-12-02 2008-10-31 Cis Bio Internat Sa Derives de l'inositol-1-phosphate
KR20100075455A (ko) 2007-09-27 2010-07-02 노파르티스 아게 약물 모니터링 분석법
US20100069356A1 (en) 2008-09-17 2010-03-18 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
WO2010043893A1 (en) 2008-10-14 2010-04-22 Astrazeneca Ab Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
JP5544024B2 (ja) 2009-12-31 2014-07-09 ケムファーム・インコーポレーテッド クエチアピンのアミノ酸結合体、その製造法及び使用法
HUE042945T2 (hu) * 2010-03-11 2019-07-29 Kempharm Inc Kvetiapin zsírsav-konjugátumai, eljárás ugyanannak elkészítésére és felhasználására
US8088594B2 (en) 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ctx1bおよび54−デオキシ−ctx1bを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
NZ722096A (en) 2011-12-15 2016-11-25 Alkermes Pharma Ireland Ltd Prodrugs of secondary amine compounds
PT3305784T (pt) * 2012-08-21 2020-10-23 Janssen Pharmaceutica Nv Haptenos de quetiapina para utilização em ensaios imunológicos

Similar Documents

Publication Publication Date Title
JP2015529198A5 (cg-RX-API-DMAC7.html)
JP2015529197A5 (cg-RX-API-DMAC7.html)
JP2015532645A5 (cg-RX-API-DMAC7.html)
EP4253075A3 (en) N,n'-diarylurea derivative, manufacturing method thereof, and thermosensitive recording material using same
JP2015527363A5 (cg-RX-API-DMAC7.html)
EA201200741A1 (ru) Способ получения этексилата дабигатрана
JP2017222671A5 (cg-RX-API-DMAC7.html)
BR112014029578A2 (pt) composto heterocíclico fundido
UY35854A (es) Métodos para la conjugación de oxima con polipéptidos ceto-modificados
EA201890450A1 (ru) Циклические динуклеотидные соединения в качестве агонистов sting
ES2571483T3 (es) Producto intermedio para producir un éster de ácido sulfónico cíclico
BR112017004899A2 (pt) detecção de proteínas mal dobradas
RU2015138503A (ru) Способ экстракции и выделения
IL291939B (en) Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid
BR112018070363A2 (pt) derivados de tetraidroisoquinolina
DK1945040T3 (da) Fremgangsmåde til fremstilling af et kaffeekstrakt og det ekstrakt som opnås derved
BRPI0922972A8 (pt) Processo de preparação de ésteres ativados, bem como sal de diciclo–hexilamina
BRPI0606676A2 (pt) processos para a preparação de derivados de ácido 4-(fenóxi-5-metil-pirimidin-4-ilóxi)piperidina-1-carboxì lico e compostos relacionados
PH12015501636B1 (en) Method for preparing 1-(4-(4-(3,4 - dichloro -2- fluorophenylamino)-7- methoxyquinazolin -6- yloxy) piperidin -1-yl) prop-2-en-1-one
WO2013132065A3 (de) Mikromechanisches messelement und verfahren zur herstellung eines mikromechanischen messelements
DK1763586T3 (da) Ny sekvens til forbedring af ekspressionen af nukleinsyre
EA201270390A1 (ru) 1,2,4-триазин, который может быть использован в качестве ускорителя вулканизации, и способ его получения
BR112015021072A2 (pt) processo de preparação de um monotriflato de isohexídeo, composto químico, processo para fabricação de um composto derivado de um monotriflato de isohexídeo, e, composto derivado
WO2016038622A3 (en) Improved process for the preparation of [[2(s)-[[4(r)-(3-hydroxyphenyl)-3(r),4-dimethyl-1-piperidinyl]methyl]-1 -oxo-3-phenylpropyl]amino]acetic acid dihydrate
MX2017011092A (es) Proceso para fraccionar un eter esterificado de celulosa.